Skip to main navigation Skip to search Skip to main content

Final report of a phase II trial of Gemcitabine (GEM) with 5FU continous infusion (CI) in the treatment of advanced pancreatic cancer (APC)

BUOSI R., OSTELLINO O., DOGLIOTTI L., FORTI G., CLERICO M., LANFRANCO C., F. BERTELLI G., GRASSI L., BUMMA C., A. SATOLLI M., BARILARO M., ALABISO Oscar

Research output: Contribution to journalArticle

Original languageEnglish
JournalTumori
Publication statusPublished - 1 Jan 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this